Pupillary response to blue light as a biomarker of seasonal pattern in major depressive episode: a clinical study using pupillometry.
Open accessAbstract
Depressive disorders are characterized by disturbances in light signal processing. More specifically, an alteration of the melanopsin response is suggested. The post-illumination pupillary response (PIPR) to blue light (post-blue PIPR) is increasingly used as a marker of the activity of intrinsically photosensitive melanopsin ganglion cells (ipRGCs). We hypothesized that individuals with Major Depressive Episode (MDE) who exhibited a higher vulnerability to season patterns showed a decreased ability to transmit light signals to the brain. We explored the correlation between the post-blue PIPR and the Global Seasonality Score (GSS) in 21 patients with MDE. The GSS was assessed using the Seasonal Pattern Assessment Questionnaire (SPAQ). The results revealed that decreased relative and absolute post-blue PIPR, suggesting a melanopsinergic hyposensitivity, were associated independently and significantly with higher seasonality in the psychological factor including a greater seasonal variation in sleep duration, mood, energy level and social activity, but were not associated with higher seasonality in the dietary factor (including weight and appetite seasonal variations) or with the severity of anxiety, depression, or sleep disturbances. Interestingly, mediation analyses highlight independent bidirectional effects of high vulnerability to season of psychological factors and decreased ipRGC sensitivity. Post-blue PIPR could be an objective marker of seasonal changes in daylight exposure in patients with MDE. Further research could explore post-blue PIPR as a state or trait biomarker for depressive disorders and the seasonal pattern, and its potential role in predicting therapeutic response to light therapy.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
High-intensity blue light causes more significant damage to the retina and photoreceptors.
“Furthermore, studies have confirmed that high-intensity blue light causes more significant damage to the retina and photoreceptors.[50]”
From Effectiveness of visible light for seasonal affective disorder: A systematic review and network meta-analysis (2025) · cites this paper as [50]
Cites
Measuring and using light in the melanopsin age
Lucas, R. J., Peirson, S. N., Berson, D. M., Brown, T. M., Cooper, H. M., Czeisler, C. A., Figueiro, M. G., Gamlin, P. D., Lockley, S. W., O’Hagan, J. B., et al. (2014) · Trends in Neurosciences · doi:10.1016/j.tins.2013.10.004 · Cited by 1,278 · see citing works
Pjrek, E., Friedrich, M.-E., Cambioli, L., Dold, M., Jäger, F., Komorowski, A., Lanzenberger, R., Kasper, S., & Winkler, D. (2020) · Psychotherapy and Psychosomatics · doi:10.1159/000502891 · Cited by 136 · see citing works
Light therapy in non-seasonal depression: An update meta-analysis
Tao, L., Jiang, R., Zhang, K., Qian, Z., Chen, P., Lv, Y., & Yao, Y. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.113247 · Cited by 129 · see citing works
Investigating the mechanism(s) underlying switching between states in bipolar disorder
Young, J. W., & Dulcis, D. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.03.019 · Cited by 68 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Wan, Y., Ding, J., Fan, M., & Huang, H. (2025) · Medicine · doi:10.1097/md.0000000000043107 · Cited by 7 · see citing works
“[50] Maybe for this reason, all the trials included in this study employed low-intensity blue light therapy.”
- Authors
- Maruani, J., Vissouze, L., Hebert, M., Rach, H., Zehani, F., Lejoyeux, M., Bourgin, P., & Geoffroy, P. A.
- Affiliations
- Inserm (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Maruani, Julia
- Geoffroy, Pierre A.
- Venue
- Psychiatry Research
- Publisher
- Elsevier BV
- Published
- 2025-02
- Volume
- 344
- Pages
- 116333
- ISSN
- 0165-1781 (ISSN-L)
- OpenAlex
- W4405611857
- Cited by
- 7
- References
- 4
- Citations by year
- 2026: 4 · 2025: 3
- FWCI
- 1.51
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Psychiatry Research (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Circadian rhythm and melatonin
- Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Light effects on plants
- Keywords
- major depressive episode, seasonal patterns, blue light, pupillometry, intrinsically photosensitive retinal ganglion cells, melanopsin, Seasonal Pattern Assessment Questionnaire, phototherapy, biomarkers
- MeSH terms
- Blue Light, Melanopsin, Adult, Major Depressive Disorder, Depressive Disorder, Major, Female, Humans, Light, Male, Middle Aged, Pupil, Reflex, Pupillary, Retinal Ganglion Cells, Seasons, Biomarkers, Seasonal Affective Disorder, Rod Opsins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review